Market Realist | Market Realist Athenex (ATNX) believes its ability to overcome challenges associated with the oral delivery of chemotherapy and intravenous delivery through its P-gp inhibitor could offer key potential benefits for patients. These developments could help patients ... |
Feeds
4051 items (4051 unread) in 74 feeds
Acinar Cell Carcinoma
(27 unread)
Acinic Cell Carcinoma
(38 unread)
Adenoid Cystic Carcinoma
(58 unread)
Adrenal Gland Cancer
(291 unread)
Ampulla Of Vater
(25 unread)
Anal Cancer
(491 unread)
Angiosarcoma
(76 unread)
Appendix Cancer
(63 unread)
Bile Duct Cancer
(490 unread)
Brain and CNS
(587 unread)
Carcinoid
(83 unread)
Endocrine/Neuroendocrine
(497 unread)
Gall Bladder Cancer
(97 unread)
Hemangioendothelioma
(18 unread)
Hepatoblastoma
(35 unread)
Pancreas
(40 unread)
Phyllodes
(13 unread)
PMP and Mucinous Tumors
(15 unread)
Rhabdomyosarcoma
(99 unread)
Sarcoma
(1008 unread)
Google - Angiosarcoma (7 unread)
-
A Look at Athenex's Research Pipeline - Market Realist
Posted: July 11th, 2018, 8:32pm GMT
-
The flipside of hairsprays - HERE. NOW
Posted: July 10th, 2018, 12:39pm GMT
HERE. NOWThe flipside of hairsprays
HERE. NOW
According to the National Institutes of Health and Family Welfare, New Delhi, vinyl chloride is a known carcinogen linked to angiosarcoma of the liver. Even more troubling is that manufacturers were aware of vinyl chloride's toxic effects for nearly a ... -
New uses for old drugs - The BMJ
Posted: June 26th, 2018, 8:07am GMT
The BMJNew uses for old drugs
The BMJ
For example, propranolol, a widely used non-selective β blocker, shows evidence of activity against a wide range of malignancies,4 including angiosarcoma, a rare soft tissue sarcoma for which current treatments produce response rates of 25-40%. Several ... -
Joel A. Thomas - The Recorder
Posted: May 16th, 2018, 12:30am GMT
Joel A. Thomas
The Recorder
May 13, 2018 Joel A. Thomas, 51, of Fort Plain, passed away peacefully on Sunday, May 13, 2018, at Bassett Medical Center, in Cooperstown, N.Y. He fought a courageous battle against an extremely rare cancer (Angiosarcoma), and was with his loving ... -
How are Korean drugmakers faring in US? - Korea Biomedical Review
Posted: May 9th, 2018, 5:01am GMT
Korea Biomedical ReviewHow are Korean drugmakers faring in US?
Korea Biomedical Review
Hanmi Pharmaceutical is taking steps to enter the U.S., too. The FDA designated Hanmi's oral treatment for cancer Oraxol as an orphan drug to treat angiosarcoma on April 20. The Korean drugmaker had signed a licensing-out deal with U.S. firm Athenex Inc. -
Angiosarcoma Diagnosis - News-Medical.net
Posted: September 11th, 2017, 4:15am GMT
News-Medical.netAngiosarcoma Diagnosis
News-Medical.net
Angiosarcoma (AS), which is a soft tissue tumor that affects the inner layer of blood and lymph vessels, is often asymptomatic in the early stages. Most of the sub-types of this disease manifest only when it has reached a serious level or has spread to ... -
What is Angiosarcoma? - News-Medical.net
Posted: August 2nd, 2017, 2:57am GMT
News-Medical.netWhat is Angiosarcoma?
News-Medical.net
Angiosarcoma (AS) is a type of soft tissue tumor that originates from the vascular endothelial cells which form the inner lining of blood as well as lymphatic vessels. This sarcoma is rare, but malignant in nature and affects any part of the body ...